The public health impact of herbs and nutritional supplements

被引:35
作者
Cassileth, Barrie R. [1 ]
Heitzer, Marjet [1 ]
Wesa, Kathleen [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ctr Study Bot Immunomodulators, Integrat Med Serv, New York, NY 10021 USA
关键词
Dietary supplements; botanicals; herbal medicines; legislation/jurisprudence; cancer; product labeling; MAITAKE BETA-GLUCAN; ALTERNATIVE MEDICINE; BREAST-CANCER; POSTMENOPAUSAL WOMEN; DIETARY-SUPPLEMENTS; COMPLEMENTARY; PREVENTION; TAMOXIFEN; GROWTH; TRIAL;
D O I
10.1080/13880200902991581
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Dietary supplement use has increased exponentially in recent years despite the lack of regulatory oversight and in the face of growing safety concerns. This article provides an overview of the public health implications and safety concerns associated with dietary supplement use, especially by cancer patients. Botanical research is actively pursued at the Memorial Sloan-Kettering Cancer Center (MSKCC) Integrative Medicine department. Work of the MSKCC Center for the Study of Botanical Immunomodulators is described, and guidelines for cancer patients' use of dietary supplements outlined. Herbs and other botanicals are complex, physiologically active agents, but little is known about most of the popular, widely available dietary supplements. Herb-drug interactions, a major concern, are exacerbated in the cancer setting. Biologically active agents may interfere with chemotherapy and other prescription medications. They may exert anticoagulant activity at rather inconvenient effective dosage, safety, and benefits of these complex agents is sorely needed. Oncology professionals and other health care providers should educate themselves and their patients about these issues. Probably the largest, continuously updated free information resource is MSKCC's AboutHerbs website (www.mskcc.org/AboutHerbs).
引用
收藏
页码:761 / 767
页数:7
相关论文
共 26 条
[11]   Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. [J].
Haller, CA ;
Benowitz, NL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1833-1838
[12]  
Ju YH, 2002, CANCER RES, V62, P2474
[13]   Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo [J].
Ju, Young H. ;
Doerge, Daniel R. ;
Woodling, Kellie A. ;
Hartman, James A. ;
Kwak, Jieun ;
Helferich, William G. .
CARCINOGENESIS, 2008, 29 (11) :2162-2168
[14]  
Kumar Nagi B, 2005, Cancer Control, V12, P149
[15]   Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production [J].
Lin, Hong ;
Cheung, Sandy W. Y. ;
Nesin, Mirjana ;
Cassileth, Barrie R. ;
Cunningham-Rundles, Susanna .
CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (01) :21-27
[16]   Maitake Beta-Glucan Enhances Umbilical Cord Blood Stem Cell Transplantation in the NOD/SCID Mouse [J].
Lin, Hong ;
De Stanchina, Elisa ;
Zhou, Xi Kathy ;
She, YuHong ;
Hoang, Danthanh ;
Cheung, Sandy W. Y. ;
Cassileth, Barrie ;
Cunningham-Rundles, Susanna .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (03) :342-353
[17]   Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol:: Evidence for type II 17β-hydroxysteroid dehydrogenase as the underlying cause [J].
Liu, ZJ ;
Lee, WJ ;
Zhu, BT .
CANCER RESEARCH, 2005, 65 (13) :5802-5811
[18]   Breast Cancer Risk in Postmenopausal Women Using Estradiol-Progestogen Therapy [J].
Lyytinen, Heli ;
Pukkala, Eero ;
Ylikorkala, Olavi .
OBSTETRICS AND GYNECOLOGY, 2009, 113 (01) :65-73
[19]   Use of complementary and alternative medicine in cancer patients: a European survey [J].
Molassiotis, A ;
Fernandez-Ortega, P ;
Pud, D ;
Ozden, G ;
Scott, JA ;
Pantelil, V ;
Margulies, A ;
Browall, M ;
Magri, M ;
Selvekerova, S ;
Madsen, E ;
Milovics, L ;
Bruyns, I ;
Gudmundsdottir, G ;
Hummerston, S ;
Ahmad, AMA ;
Platin, N ;
Kearney, N ;
Patiraki, E .
ANNALS OF ONCOLOGY, 2005, 16 (04) :655-663
[20]  
*NMI, 2007, HLTH WELLN TRENDS